IBOGAINE
is a drug produced by extraction from the roots of 7irberrrollrlre iboga, a plant commonly found in Africa.
There is anecdotal evidence that one injection of ibogaine elimiuares addiction to drugs such as heroin, morphine, and cocaine. There has not been a large number of animal studies with ibogaine. In one study, ibogaine was given to rats that had been trained to bar press for morphine, and was found to protluqa dose-rclatcd decrease in bar pressing (4). This effect W;IS ob.\crvcd Cur up to several days after a single administratioll.
In :I diftrrcnt study, a single injection of ibogaine decreased cocaine self-administration for several days, and with repeated iboggine injections cocaine intake was significantly dec~casetl for weeks (1). Ibogaine also has been shown to rcducc the effects of naloxone-precipitated withdrawal symptom5 from morphine (5) . It has been shown that development of drug tolerance, drug addiction, withdrawal from drug addiction, and drug craving are influenced not only by mechanisms of reward and incentive motivation, but also by mechanisms of learning and memory. Current theories have proposed that operant and classical conditioning, habituation, and sensitization play a very important role in determining the level of drug tolerance, drug addiction, drug withdrawal, and drug craving (7, 12, 14, 16) . It is therefore possible that the inhibitory effects of ibogaine on drug addiction and drug craving might be due to a general interference with learning and memory processes. The hippocampus is known to play an important role in Icarning and memory (3, 6, 17) . It was therefore of real interest to discover that rats will self-administer dynorphin A (opiate agonist) injected directly into the CA, region of the hippocampus (18) . The authors suggest that craving and compulsive drug seeking may depend on memory for past drug reinforcements, and because the hippocampus is important in learning and memory, it may play a critical role in drug addiction and drug craving. The possibility exists that ibogaine's blockade of ' To whom rcqucsts for reprints should be addrrsscd drug addiction is due in part to its actions on the hippocampus, and therefore on learning and memory processes. The purpose of lhc prcscnt study was to test this idea by selection of ;I sp;llial n:lvig;ltiorl Icarning t;tsk that is known to bc scnsilive lo hil~poc:~n~l~;~l tlysl'ul~ction (9) . I lowcvcr, hcforc WC could examine the effects of ibogaine on spatial navigation learning, it was necessary to determine the effects of different doses of ibogaine on sensory motor function as well as general activity level, so that the appropriate doses could be selected for the learning study. 
Methods
The subjects consisted of eight naive male Long-Evans rats, approximately 100 days old. Each animal was given the entire battery of neurologic tests, once per day for a block of 4 consecutive days. Following a 3-day interval, the rats were again given a block of four consecutive sessions. Each animal was injected with either 10, 20, 30, 40, 50, or 60 mg/kg [intraperitoneally (IP)] of ibogaine or vehicle (sterile water) 30 min before testing each day. Ibogaine was supplied by NIDA. Every animal was tested once with each drug dose and twice with vehicle. Half of the rats received low doses of ibogaine (0, 10, 20, and 30 mg/kg) on the first block of four sessions, and the higher doses (0, 40, 50, and 60 mg/kg) on the second block of four sessions. For purposes of counterbalancing the effects of ibogaine, the other four rats received the higher doses on the first block and the lower doses on the second block of four sessions using a Latin square design. The animals were placed in a small box (30 x 45 x 10 cm) and allowed 10 s to adjust to the surroundings before each of the neurologic tests was administered.
l'i.crtrr/ .vlirrrrr/rrs oCcr~li/~g /CT/. A 5 5-cm cardboard square with a checkered pattern of black and white, 2.5-cm squares attached to a wooden stick was used. This square was held in the peripheral field of vision on either side of the animal's head. A response was defined as orienting to the checkered square, and the latency to respond was measured by a second experimenter using a stopwatch. A maximum score of 60 s was given when the animal failed to respond. Two measurements were taken one frorn the right and the other from the left of the rat. The average of the two latencies was used as a measure of visual detection.
Whisker touch orienting test. A cotton swab was brought from behind the animal's head and put in contact with the vibrissae. The vibrissae were continually stirnulated while the swab was held outside the rat's field of vision until a response occurred or a maximum of 60 s was reached. The test was given successively on each of the rat's right and left sides. The latency to respond (orient toward the swab) was measured. The average latency of the two responses was used as a measure of whisker touch detection.
Olfuctory orienting test. Twenty-one different distinctive scents, including, for example, mint, lemon, and root beer, were used in this test. To decrease the possibility of tolerance, the odors were randomly chosen for each test with no repetition within a 4-day block. A cotton swab was moistened with the preselected scent and brought from behind the animal's head, so that it remained out of the field of vision and did not touch the anirnal. Each of the rats was exposed to two scents, boll1 of which were presentecl from its right and left sides. The KESNER 11'1' Al,. latency to orient was recorded and the average of the four tests was used as a measure of olfactory detection.
Sornatosensor,y orienting te.yt. A thin wire (30 cm long) was applied to and held again9 the animal's shoulders, midsection, and hind cltlartcrs (with gcntlc prcssurc) on both right and Icft sides. The animal's latency to orient to each touch was recorded, and the average of the six response times was used as a rneasure of somatosensory detection.
Sensory-Motor Tests
Pkucing rrf/ex test. The rat was first suspcndcd by the tail and then brought to the edge of a table. Normal animals reach for the edge of a table by forelimb extension when brought within reach of it. When the animal responded using only the sight of the table, the animal was given a score of 1; when it required touch of the vibrissae to the table, the score was 0.75; when it required touch of the snout, the score was 0.50; and when it required additional touching of the snout to the table, the score was 0.25. When no response was elicited, the score given was 0.
Titled platform test. Each animal was placed at the center of a 30 x 30-cm plywood platform covered with carpet. The platform was tilted at 30° and the animal was placed with its head pointing toward the low end. Normai animals respond by turning uphill facing the high end of the platform. The latency to turn around and face uphill perpendicular to the front end was measured, and a maximum score of 60 s was used.
Motor Tests
Grasping ref/ex. Each animal was suspended by lhe nape' of the neck, and both front feet were touched by a single piece of thin wire. The rating scale used was a score of I for grasping the wire and 0 for no response. A nortnal animal will flex its digits around the wire, grasping tightly.
Righting ref/ex (hack). For this test each animal \vas l>li\cctl on its back and released. When the animal righted itself. a score of I was given. When the animal failed to right itself, :I score of 0 was given.
Righting reJe.y (free full). Each animal wa$ hrld upG(lc down 20 cm above a foam pad and released. When the nninr;ll righted itself in midair, landing on its feet, a score of 1 w:l$ given. When the animal failed to right itself completely. a score of 0 was given.
RESUI.TS
The effect of ibogaine injections on mean latency to re. spond to the visual stimulus is shown in Table I . As closes of ibogaine increased from O-60 mg/kg there was a corresponding increase in latency to respond to the visual stimulus. A one-way within-subject analysis of variance (ANOVA) indcated that there was a significant drug dose effect [I,'(6, 114) = 16.7, p < O.OOOl]. Further Newman-Keuls tests revealed that doses of 30, 40, 50, and 60 mg/kg of ibogaine resulted in significantly (II < 0.01) longer latencies in comparison with vehicle control (0 mg/kg). Table 1 also shows the effect of ibogaine injections on latency to respond to the olfactory stimulus. As the table indicates, as doses of ibogaine increased there was a corresponding increase in latency to respond to the olfactory stimulus. A one-way within-subject ANOVA indicated that there was a significant drug dose effect [1; (6, 50, and 60 n&kg of ibogaine resulted in significantly (p < 0.01) longer latencies in comparison with vehicle control. The effect of ibogaine injections on mean latency to respond to the somatosensory stimulus is also shown in Table  I . As tlo~s of ibogaine increased there was a corresponding increase in latency to respond to the somatosensory stimuli. A one-way withh-subject ANOVA indicated that there was a significant drug dose effect [F(6, 114) = 14.2, p < O.OOOl]. Further Newman-Keuls tests revealed that doses of 30, 40, 50, and 60 mg/kg of ibogaine resulted in significantly (p < 0.05) #,ltinger latencies in comparison with vehicle control. Table I also shows the effect of ibogaine injections on mean latency to respond to whisker touch. As doses of ibogaine increased, there was a corresponding increase in latency to resppnd to the whisker touch stimulus. A one-way withinsubject ANOVA indicated that there was a significant drug Finally, the effect of ibogaine injections on mean latency to respond to the tilted platform is shown in Table 1 . The table indicates that ibogaine produced an increase in latency to respond compared to the vehicle control condition. A one-way within-subject ANOVA revealed that there was a significant drug dose effect (F(6, 114) = 4.36, p < O.OOOS]. Further Newman-Keuls tests revealed that ai all doses but the 50 mg/ kg dose of ibogaine the rats had significantly (p < 0.05) longer latencies in comparison with vehicle control rats.
The effect of ibogaine injections on the mean placing reflex score is shown in Table 2 . Ibogaine disrupted the appropriate execution of the placing reflex only at the 50-mg/kg ibogaine dose. A one-way within-subject ANOVA revealed that there was a significant drug dose effect [F(6, 114) = 12.1, p < 0.001). Further Newman-Keuls tests indicated that the dose of 50 mg/kg of ibogaine resulted in a significantly lower score compared to all the other doses (p < 0.01).
The effect of ibogaine injections on the mean grasping reflex score is also shown in Table 2 . lbogaine disrupted the appropriate execution of the grasping reflex only at the 40-and 50-mg/kg ibogaine doses. A one-way within-subject AN-OVA revealed that there was a significant drug dose effect [F(6, 114) = 3.4, p < 0.0041. Further Newman-Keuls tests indicated that doses of 40 and 50 mg/kg ibogaine resulted in significant lower scores compared to the other doses (p < 0.01). Table 2 shows the effect of ibogaine injections on the mean righting reflex (back) score. Ibogaine disrupted the execution of the righting reflex starting at doses of 40 mg/kg ibogaine and above. A one-way within-subject ANOVA revealed that there was a significant drug dose effect [F(6, 114) = 11.4, p < O.OOOl]. Further Newman-Keuls tests indicated that doses of 40, 50, and 60 mg/kg of ibogaine resulted in significantly lower scores compared to the other doses (p < 0.01).
Finally, the effect of ibogaine injections on mean free fall righting reflex score is shown in Table 2 . Ibogaine disrupted the execution of the righting reflex (free fall) starting at doses of 30 mg/kg ibogaine and above. A one-way within-subject ANOVA revealed that there was a significant drug dose effect (F(6, 114) = 5.1, p < O.OOOl]. Further Newman-Keuls tests indicated that doses of 30, 40, 50, and 60 mg/kg of ibogaine resulted in significantly lower scores compared to 0, 10 and 20 mg/kg ibogaine (p < 0.05).
Discussion
The results point to a reduction in detection of sensory information as indicated by longer latencies to respond. This reduction in sensory responsiveness was already evident at doses of 20 mg/kg of ihogaine for the olfactory aud whiskertouch orienting ICSIS. AI doses of 40 rug/kg ibogahle, reduction in detection of sensory information was observed in all of the sensory assessment tests. Furthermore, in general, the higher the dose of ibogaine the greater the sensory impairment. Thus, ibogaine has a marked disruptive effect on detection of sensory input.
With respect to sensory-motor function, ibogaine disrupted performance on the tilted platform test at the lowest dose (IO mg/kg). This test is sensitive to vestibular and cerebellar function and is consistent with a recent report that ibogaine has deleterious actions on cerebellar function (13) . With respect to tests of motor function, in general, problems did not appear until doses of 40-50 mg/kg ibogaine.
Thus, ihogaine appears to have its greatest effects on tests of vestibular and cerebellar function, followed by effects on sensory function, and then motor functions. The rats under the influence of ibogaine were not very active. It was thus important to employ a standard test of activity to quantify the effects of ibogaine on the level of activity.
The effect of ibogaine (0, IO, 20, 30, or 40 mg/kg) on activity and emotionality was assessed in an open field. Because doses of 50 and 60 mg/kg ibogaine severely impaired motor responses, these dose levels were not used in the activity experiment.
Methods
The apparatus used was a large, open wooden box (120 x 120 cm) with 30-cm-high walls. The floor of the box was painted white and divided by black tines forming 64 square sections (15 x 15 cm). The subjects were 40 Long-Evans rats, dcprivcd to and maintained at 80-8570 of free-feeding body weight. For the open field experiment, eight rats in each group were assigned a dose (0, IO, 20, 30, or 40 mg/kg) of ibogaine, which remained consistent throughout the testing period. Thirty minutes after IP injection, each animal was placed in the center of the open field for 10 min. The mean number of squares entered was used as a measure of locomotor activity.
Grooming, scratching, righting, and washing behaviors were recorded and combined into a single nonlocomotor activity score. Emotionality was measured by the occurrence of urination and defecations, and these were combined for an emotionality score. Testing was conducted on each of 3 consecutive days.
Results
The effect of ibogaine injections on locomotor activity the higher doses (30-40 m&kg) of ibogaine were very inactive and appeared to be in a state of suspension. These results are consistent with the observation of reduced locomotor activity in mice injected with 80 mg/kg of ibogaine (15) . It has been shown that ibogaine produces immediate and delayed changes in dopamine metabolism in nucleus accumbens, striatum, and prefrontal cortex and that these changes relate to decreases in morphine-induced locomotor activity (11). Thus, it is likely that changes in locomotor activity are due to ibogaine action on dopaminergic brain systems. The enhanced efficacy in reducing activity levels for the IO-mg/kg group with repeated trcatmznts could have been due to cumulative effects of the rl~ug. I'urthermore, the ibogaine-injected rats were less emotional compared IO the vehicle-injected rats. This is significant bscause it indicates or suggests that the reduced activity of iboyain~-injected rats was not a result of an enhanced fear rcspon~c~ to thq open field. It is not clear why the 20-mg/kg ibogaillc-injcctrd rats showed greater emotionality compared IO ihc IO-mg/kg group.
l:Sl'~KltvIHN 1' 3: LEAKNING TASKS liven though iboga/ne has marked effects on detection of sensory stimuli and reduces activity level, it was stilt important to dctcrminc whether these effects would lead to learning and IIICI~IOI y problenls. To measure the effects of ibogaine on learning and memory, rats were trained on a spatial location mcmury task in a dry-land version of a water maze. This task h;ls been shown to be sensitive to hippocampal dysfunction.
.* i@po~rus. The apparatus (cheeseboard) was made of 3.3-cm-thick wood, painted white and elevated 26 cm from the floor. It was circular with a diameter of 119 cm. It contained 177 evenly spaced, round holes (2 cm in diameter and 1.5 cm deep) spaced 4 cm apart. The walls of the room contained pictures as extramaze visual cues. The trials were monitored by a video camera positioned directly above the maze, which fed into a tracking system consisting of an image analyzer (HVS Ltd. VP 110) coupled to an Apple He computer. A light-emitting diode attached to Velcro tape was placed onto the rat's body for tracking purposes.
Behovioralprocedtrres. Pretraining involved attaching Velcro tape to an animal and allowing it to explore the apparatus with food (Froot Loop cereal) in half of the food wells. This enabled the rats to habituate to the cheeseboard environment. The animals were familiarized with the apparatus for 6 days. After the 2nd day the number of food wells containing Froot Loops was reduced to 35, and on the 5th day to 25.
On the 7th day the animals were assigned a specific food location (one food welt containing once piece of Froot Loop cereal) in one of the four quadrants of the apparatus; this location remained consistent throughout testing. Thirty minutes before testing the animals were injected with 0, IO, 20, or 30 mg/kg of ibogaine; each drug-dose group contained eight subjects. The animals were given eight trials pzr day with two trials at each of the four starting locations. The intertrial intervat was a minimum of 5 s. Each trial consisted of placing an animal on the edge of the apparatus facing the wall at one of the four starting locations. The animal was allowed to search for the food well containing the Froot Loop cereal until it found the correct hole and ate the food, or until 120 s had transpired. The latency to find the correct food well was used as the dependent measure. On the following 2 days each animat received the same drug treatment 30 min before testing and was given an additional eight trials using the same proccdure previously described.
The results are shown in Fig. 4 . In the spatial location learning task, rats with IO, 20, or 30 mg/kg ibogaine injections could not learn the task, as indicated by tong tatencies to find the food location.
An ANOVA of the latency data with drug dose as the between-subject variable and blocks of trials as the withinsubject variable revealed a significant effect of drug dose [F(3, 28) = 25.2, p < O.OOl] and a significant effect of blocks of trials [F(S, 140) = 3.2, p < 0.0091. The observation of a significant effect of blocks without a significant interaction of drug dose and blocks indicates that all the rats improved across trials. Based 011 subsequent Newman-Keuts tests, rats that received ibogaine were significantly different from satineinjected rats (p < O.Ot), but not from each other. (1t111111 IIII 11111111 lIl~,l~,  ,lltll~~ll,?ll  IIll I, \V,,' , ,, ~,11,'111 ,1,1,1,11\1 I,11 III 111 ,l1!,!, 111ir1\ I lllh could be due in part to lhe reduction in locomotor activily, and thus, tlifficultics in a scnrchinR r0r the location 0r the rd. l'his inahilily to learn could also hc due lo a reduction in the ability to detect visual stimuli. Therefore, one cannot clearly assess the effects of ibogaine 011 lcnrning and memory in this task, because of its marked cllccts on activity level and sensory-motor runctions.
EXPERIMENT 4: LONG-TERM EFFECTS OF IBOGAINE
Even though the acute effects of ibogaine on sensorymotor function, activity, and learning are rather profound, we needed to determine whether a single dose of ibogaine would have long-term consequences on sensory-motor function and learning of a spatial location task.
Methods
Thus, new rats (n = 30) were injected (II') with either the vehicle (n = 14) or ibogaine (n = 16) (40 mg/kg) and subsequently tested for learning of the spatial location task I day [vehicle (n = 9), ibogaine (n = IO)] or 7 days [vehicle (n = 5) and ibogaine (n = 6)j later using the same procedure described in Experiment 3, the spatial location task.
In addition, of the 19 rats that were tested in the spatial location task I day later, eight (four vehicle and four ibogaine) were tested for sensory-motor function using the same procedures described in Experiment 1 before the 1st day of testing in the spatial location task, and I1 (five vehicle and six ibogaine) were tested for sensory-motor function immediately after the last day of testing (day 3) in the spatial location task. Of the 11 rats that were tested in the spatial location task 7 days later, all I1 (five vehicle and six ibogaine) were tested for sensory-motor function immediately after the last day of testing (day 9) in the spatial location task.
Results
After a single 40-mg/kg ibogaine injection, there were no neurologic problems on the I-, 3-, or IO-day neurologic tests for visual and somatosensory information or motor tests (placing, grasping, and righting reflexes). Even though this was not assessed formally, the rats were not inactive l-l I days after the ibogaine injection. As an illustration of the lack of effect of ibogaine, results are shown for the olfactory and whisker-touch sensory tests, and the tilted platform test for the vehicle and 40-mg/kg ibogaine groups tested 30 min after injection (from Experiment I) and vehicle or 40-mg/kg ibogaine groups tested 24 h after injection (Table 3) . Relative to the 30-min ibogaine-injection test, there were no problems 24 h following an ibogaine injection.
A two-way ANOVA with dose (0 or 40 mg/kg ibogaine) and test interval (30 min vs. 24 h) as the two factors was performed on latency to respond to olfactory stimuli, and revealed a significant dose effect [F(l, 41) = 10.6, p < 0.0031, a significant interval effect [Ql, 41) = 11.2, p < 0.002, and a significant dose x interval interaction [F(I, 41) = 9. Data are means/SE (me/kg).
to the tilted platform revealed primarily a significant interval effect [F(l, 41) = 4.5, p < 0.041 with a dose effect almost reaching significance [F(l, 41) = 3.7, p < 0.061. The results of a single injection of 0 or 40 mg/kg of ibogaine I or 7 days before testing on mean latency to find the correct food location are shown in Figs. 5 and 6, and indicate that there was a significant disri&ive effect on spatial learning l-3 days after the ibogaine injection, but no long-term consequence 7-9 days later. An ANOVA of the latency data I day after injection with drug dose as the between-subject variable and blocks of trials as the within-subject variable revealed a significant dose effect [F(l, 17) = 4.5, p < 0.051, but no significant trials or significant dose x trials interaction effect. Thus, a single injection of ibogaine produced a disruption in learning the spatial location task. A similar ANOVA on the latency data 7 days after injection revealed only a significant block of trials effect [F(5, 45) = 4.3, p < 0.003], but no significant dose or significant dose x trial interaction effect, indicating that both groups learned the task.
Discussion
The results of this last experiment suggest that evin thorYg% ibogaine has no long-term consequences on sensory-motor function, there are significant effects on the acquisition rl' a spatial navigation task l-3 days after a single injection of 40 mp/kg of ibogaine. This long-term effect appears to be time limited, because only a small nonsignificant effect on learning was found 7-9 days after a single injection of 40 mg/kg of ibogaine.
Thus, ibogaine at doses of IO-40 mg/kg can produce marked impairments on activity, sensory-motor function, and learning while the subject is under the influence of the drug, as well as a long-term effect on learning that cannot be due to deficits in sensory-motor function or marked changes in activity level. It is not clear how ibogaine can produce long-term effects on learning ability, especially because the half-life of ibogaine in rats is about I h (2). Similar long-term effects of ibogaine on behavior have been described elsewhere (4, I 1). It is not known whether a metabolite of ibogaine has a long half-life or whether ibogaine produces long-term changes in specific neural transmitter systems. It has been shown that ibogaine can decrease the levels of dopamine metabolites at least for 19 h after an ibogaine injection (I I).
The long-term deficits of ibogaine on the dry-land version of the water maze spatial navigation task are similar to what has been reported for rats with hippocampdl lesions (9), suggesting the possibility that long-term effects of ibogaine could be based on its influence on hippocampal learning and memory function. It sl~oulil IX nolcd that ihgainc also Iwi cfl'ccls on the doparnincrgic syslem within nucleus nccu~nbc~ls, prcfrontal cortex, and striatum (IO,1 I), and thus could alter reward mechanisms as well. However, lesions of the striatum or medial prefrontal cortex do not produce marked deficits in spatial navigation tasks (8,9). It is a possibility that ibogaine has effects on addiction via a dual action on reward as well as learning and memory mechanisms. The present study indicates that ibogaine has effects on learning and memory. Whether ibogaine affects learning and memory processes associated with tolerance development, addiction, withdrawal from addiction, and craving needs to be assessed.
